Company intelligence / Profile preview

Farmless

Ownership: Private
Development stage: Preclinical

Overview

Farmless has developed a proprietary biomass fermentation process that uses renewable energy and a liquid feedstock made from carbon dioxide, hydrogen, and nitrogen to grow microorganisms as a source of complete-protein food ingredients. The company has raised significant funding to build a pilot facility and aims for regulatory approval in the near future. No clinical results are relevant as this is not a therapeutic company.

Modalities: Microbial proteinSingle cell proteinBiomass fermentation
Industry: Non-Drug Biotech

Partnerships

No major pharmaceutical or biotech partnerships reported; collaborates with innovation hubs such as Planet B.io

Beyond the preview

Go deeper on Farmless.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Farmless.

Explore the full profile